A novel angiogenesis-associated risk score predicts prognosis and characterizes the tumor microenvironment in colon cancer.

Our study elucidated the role of angiogenesis characteristics in CC and the AAGs score could help clinicians plan for individual management with chemotherapy agents and promote the development of immunotherapy in CC. Prospective studies need to be conducted to further confirm our findings.